As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/9/24  Cytosorbents Corp.                8-K:2,9      5/9/24   11:308K                                   Toppan Merrill/FA        
  5/9/24  Cytosorbents Corp.                10-Q        3/31/24   60:6.4M                                   Toppan Merrill/FA2       
  5/6/24  Cytosorbents Corp.                8-K:5,9      5/2/24   11:341K                                   Toppan Merrill/FA        
 4/19/24  Cytosorbents Corp.                ARS        12/31/23    1:14M                                    Toppan Merrill/FA        
 4/19/24  Cytosorbents Corp.                DEFA14A                1:407K                                   Toppan Merrill/FA        
 4/19/24  Cytosorbents Corp.                DEF 14A      6/6/24    1:1.4M                                   Toppan Merrill/FA        
  4/4/24  Jones Edward Raymond              4          Director²   1:5K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/4/24  Deliargyris Efthymios             4          Officer²    1:8K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/4/24  Sobel Alan D.                     4          Director²   1:5K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/4/24  Bloch Kathleen P.                 4          Officer²    1:8K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/4/24  Bator Michael G.                  4          Director²   1:5K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/4/24  Capponi Vincent                   4          Officer²    1:8K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/4/24  Kim Jiny                          4          Director²   1:5K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/4/24  Chan Phillip P.                   4          Dir.,Off.²  1:8K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/3/24  Cytosorbents Corp.                8-K:5,9     3/29/24   12:282K                                   Toppan Merrill/FA        
  4/2/24  Deliargyris Efthymios             4          Officer²    1:5K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/2/24  Capponi Vincent                   4          Officer²    1:5K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/2/24  Bloch Kathleen P.                 4          Officer²    1:5K   Cytosorbents Corp.                Toppan Merrill/FA        
  4/2/24  Chan Phillip P.                   4          Dir.,Off.²  1:5K   Cytosorbents Corp.                Toppan Merrill/FA        
 3/15/24‡ Cytosorbents Corp.                8-K:2,9     3/14/24   11:343K                                   Toppan Merrill/FA        

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:  -A
	4	Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	10-Q	Quarterly Report — Form 10-Q.
	ARS	Annual Report to Security Holders.
	DEF 14A	Definitive Proxy Statement — Schedule 14A.
	DEFA14A	Definitive Additional Proxy Soliciting Material — Schedule 14A.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.